What is the current Price Target for the Medicenna Therapeutics Corp stock?

The average Medicenna Therapeutics Corp target price is $3.52. This is 199.33% higher than the current stock price. The highest price target is 410.64%, the lowest is 52.73%. 4 Analysts have issued a price target Medicenna Therapeutics Corp 2025 .

How high will the Medicenna Therapeutics Corp stock rise?

No reliable answer can be given as to how high the Medicenna Therapeutics Corp stock will rise. The performance of stocks, including the Medicenna Therapeutics Corp stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Medicenna Therapeutics Corp stock today?

The performance of Medicenna Therapeutics Corp stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Medicenna Therapeutics Corp stock fall?

The decline in Medicenna Therapeutics Corp stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Medicenna Therapeutics Corp Forecast, price target & analysts

$1.18

4.07%

Nasdaq, Mon, Nov 25 2024

ISIN

CA58490H1073

Symbol

MDNA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts Strategies

Medicenna Therapeutics Corp Target price 2024 - Analyst rating & recommendation

Medicenna Therapeutics Corp Classifications & Recommendation:

Buy

100%

Medicenna Therapeutics Corp Price Target

Target Price	$3.52
Price	$1.18
Potential	199.33% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target Medicenna Therapeutics Corp 2025 . The average Medicenna Therapeutics Corp target price is $3.52. This is 199.33% register free of charge higher than the current stock price. The highest price target is $6.00 410.64% register free of charge , the lowest is $1.79 52.73% register free of charge .
	A rating was issued by 4 analysts: 4 Analysts recommend Medicenna Therapeutics Corp to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Medicenna Therapeutics Corp stock has an average upside potential 2025 of 199.33% register free of charge . Most analysts recommend the Medicenna Therapeutics Corp stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Annually

	Mar '24	2025 Estimates
Earnings Per Share $	-0.27	-0.17
	125.00%	37.04%
P/E		negative

The average Medicenna Therapeutics Corp <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024.

This results in the following potential growth metrics and future valuations:

2024	$-0.27	125.00%
2025	$-0.17 37.04% Unlock
2026	$1.58 1,029.41% Unlock

Current	-4.25	54.55%
2025	-6.91 62.59% Unlock
2026	0.74 110.71% Unlock

Medicenna Therapeutics Corp...

Discover more stocks with a high price target

Valneva 284.61%

CureVac N.V. 145.33%

Moderna 70.75%

Bavarian Nordic 61.25%

Nel ASA 44.74%

Aixtron 43.84%

Volkswagen VZ 41.85%

Alibaba Group Holding Ltd 40.45%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now